179 related articles for article (PubMed ID: 2949193)
1. [Is the HTLV III/LAV virus the causative agent of AIDS or merely an agent of one of the opportunistic infections?].
Hollán Z
Orv Hetil; 1986 Dec; 127(52):3219-20. PubMed ID: 2949193
[No Abstract] [Full Text] [Related]
2. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
3. [Immunopathogenesis and therapeutic approaches in acquired immunologic deficiency syndrome (AIDS)].
Zielinski C
Acta Med Austriaca; 1987; 14(1):5-9. PubMed ID: 2956821
[TBL] [Abstract][Full Text] [Related]
4. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
[TBL] [Abstract][Full Text] [Related]
5. Antibody to human lymphotropic virus type III: immunologic status of homosexual contacts of patients with the acquired immunodeficiency syndrome and the acquired immunodeficiency-related complex.
Goldsmith JM; Kalish SB; Ostrow DG; Britz J; Chmiel JS; Wallemark CB; Phair JP
Sex Transm Dis; 1987; 14(1):44-7. PubMed ID: 2951878
[TBL] [Abstract][Full Text] [Related]
6. [Acute AIDS-retrovirus infection. Clinical picture in a patient with HTLV-III seroconversion].
Eberhartinger C; Simader R
Wien Klin Wochenschr; 1987 Jan; 99(1):18-20. PubMed ID: 2951926
[TBL] [Abstract][Full Text] [Related]
7. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P
Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638
[TBL] [Abstract][Full Text] [Related]
8. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
Abe T
AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
10. [Thrombopenic purpura in a group of addicts addicted to parenteral drugs with anti-HTLV-III/LAV antibodies and inversion of the T-helper/T-suppressor cell quotient].
Aguilar Ligorti E; Guix García J; Ample Guillén I; Balaguer Martínez JV; Marugán de la Concha I; García-Conde Bru J
Sangre (Barc); 1986; 31(4):401-10. PubMed ID: 2947340
[No Abstract] [Full Text] [Related]
11. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
12. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
Margolick JB; Volkman DJ; Folks TM; Fauci AS
J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
[TBL] [Abstract][Full Text] [Related]
13. Biological properties of HTLV-III/LAV: a possible pathway of natural infection in vivo.
Popovic M; Read-Connole E; Gartner S
Ann Inst Pasteur Immunol; 1986; 137D(3):413-7. PubMed ID: 2950906
[No Abstract] [Full Text] [Related]
14. Extrathecal and intrathecal IgG response to the AIDS virus LAV/HTLV-III in experimental infection of chimpanzees.
Goudsmit J; Gibbs CJ; Asher DM; Gajdusek DC
Cancer Detect Prev Suppl; 1987; 1():509-14. PubMed ID: 3480064
[TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of the acquired immunodeficiency syndrome.
Bowen DL; Lane HC; Fauci AS
Ann Intern Med; 1985 Nov; 103(5):704-9. PubMed ID: 2996403
[TBL] [Abstract][Full Text] [Related]
16. [Activation of the macrophage/lymphocyte system in AIDS, ARC and AIDS risk groups].
Wachter H; Blecha HG; Fuchs D; Hausen A; Hengster P; Hinterhuber H; Reibnegger G; Reissigl H; Rössler H; Schönitzer D
Wien Klin Wochenschr; 1986 Jul; 98(14):449-54. PubMed ID: 3019018
[TBL] [Abstract][Full Text] [Related]
17. Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS.
Rogers MF; Ewing EP; Warfield D; Hardy AM; Emery DR; Wolf GC
Obstet Gynecol; 1986 Sep; 68(3 Suppl):2S-6S. PubMed ID: 3016628
[TBL] [Abstract][Full Text] [Related]
18. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
[TBL] [Abstract][Full Text] [Related]
19. [AIDS: is Retrovirus HTLV-III the causative agent?].
Thiele HG
Immun Infekt; 1984 Oct; 12(5):256-8. PubMed ID: 6334015
[No Abstract] [Full Text] [Related]
20. Immunoregulatory defects associated with infection with the AIDS virus, HTLV-III.
Crapper RM; Frazer IH; Mackay IR; Iscaro A; Bradford DL
Concepts Immunopathol; 1987; 4():243-60. PubMed ID: 3297337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
